Exane Derivatives’s Arlington Asset Investment Corp. AAIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-16,985
Closed -$123K 717
2018
Q4
$123K Hold
16,985
0.02% 299
2018
Q3
$162K Buy
16,985
+8,427
+98% +$86K 0.03% 266
2018
Q2
$88.8K Buy
8,558
+1,357
+19% +$15.1K 0.01% 350
2018
Q1
$78.8K Buy
7,201
+6,193
+614% +$70.1K 0.02% 324
2017
Q4
$11.9K Sell
1,008
-1,982
-66% -$23.9K ﹤0.01% 394
2017
Q3
$38.1K Buy
2,990
+1,921
+180% +$25.3K 0.01% 327
2017
Q2
$14.6K Sell
1,069
-1,601
-60% -$23K ﹤0.01% 376
2017
Q1
$37.7K Buy
+2,670
New +$39.3K 0.01% 285

Other funds holding AAIC

Exane Derivatives's AAIC Position: Q1 2019 in Review

Exane Derivatives sold out of Arlington Asset Investment Corp. (AAIC) in Q1 2019, closing a stake of 16,985 shares — an estimated $123K sold.

Exane Derivatives first reported a position in AAIC in Q1 2017 and held it in 8 quarters. The position peaked at $162K in Q3 2018. 86 funds tracked by Wall St. Rank hold AAIC as of Q1 2019.

  • Exane Derivatives reported no remaining Arlington Asset Investment Corp. position as of Q1 2019 after selling out during the quarter.
  • Exane Derivatives sold 16,985 Arlington Asset Investment Corp. shares in Q1 2019, an estimated $123K.
  • Exane Derivatives first reported a position in Arlington Asset Investment Corp. in Q1 2017 and held it in 8 quarters.
  • Exane Derivatives's Arlington Asset Investment Corp. position peaked at $162K in Q3 2018.
  • 86 funds tracked by Wall St. Rank held Arlington Asset Investment Corp. as of Q1 2019.

Based on Exane Derivatives's 13F filing for Q1 2019, filed 24 Apr 2019.